Literature DB >> 30603750

Applications of nanoparticles in biomedical imaging.

Xiangjun Han1, Ke Xu, Olena Taratula, Khashayar Farsad.   

Abstract

An urgent need for early detection and diagnosis of diseases continuously pushes the advancements of imaging modalities and contrast agents. Current challenges remain for fast and detailed imaging of tissue microstructures and lesion characterization that could be achieved via development of nontoxic contrast agents with longer circulation time. Nanoparticle technology offers this possibility. Here, we review nanoparticle-based contrast agents employed in most common biomedical imaging modalities, including fluorescence imaging, MRI, CT, US, PET and SPECT, addressing their structure related features, advantages and limitations. Furthermore, their applications in each imaging modality are also reviewed using commonly studied examples. Future research will investigate multifunctional nanoplatforms to address safety, efficacy and theranostic capabilities. Nanoparticles as imaging contrast agents have promise to greatly benefit clinical practice.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30603750     DOI: 10.1039/c8nr07769j

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  39 in total

1.  A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model.

Authors:  Alexander P Klapproth; Maxim Shevtsov; Stefan Stangl; Wei Bo Li; Gabriele Multhoff
Journal:  Int J Nanomedicine       Date:  2020-06-30

2.  Amphiphilic DTPA Multimer Assembled on Icosahedral Closo-Borane Motif as High-Performance MRI Blood Pool Contrast Agent.

Authors:  Lalit N Goswami; Shatadru Chakravarty; Quan-Yu Cai; Erik M Shapiro; M Frederick Hawthorne; Lixin Ma
Journal:  ACS Appl Bio Mater       Date:  2021-08-25

Review 3.  Nanotechnology as a Versatile Tool for 19F-MRI Agent's Formulation: A Glimpse into the Use of Perfluorinated and Fluorinated Compounds in Nanoparticles.

Authors:  Joice Maria Joseph; Maria Rosa Gigliobianco; Bita Mahdavi Firouzabadi; Roberta Censi; Piera Di Martino
Journal:  Pharmaceutics       Date:  2022-02-09       Impact factor: 6.321

Review 4.  Silver chalcogenide nanoparticles: a review of their biomedical applications.

Authors:  Lenitza M Nieves; Katherine Mossburg; Jessica C Hsu; Andrew D A Maidment; David P Cormode
Journal:  Nanoscale       Date:  2021-12-02       Impact factor: 7.790

5.  Biodegradable Hypericin-Containing Nanoparticles for Necrosis Targeting and Fluorescence Imaging.

Authors:  Xiangjun Han; Olena Taratula; Oleh Taratula; Ke Xu; Anna St Lorenz; Abraham Moses; Younes Jahangiri; Guibo Yu; Khashayar Farsad
Journal:  Mol Pharm       Date:  2020-04-07       Impact factor: 4.939

6.  Development of a Sensitive Assay to Screen Nanoparticles in vitro for Complement Activation.

Authors:  Nuzhat Maisha; Tobias Coombs; Erin Lavik
Journal:  ACS Biomater Sci Eng       Date:  2020-07-06

7.  Silver telluride nanoparticles as biocompatible and enhanced contrast agents for X-ray imaging: an in vivo breast cancer screening study.

Authors:  Lenitza M Nieves; Jessica C Hsu; Kristen C Lau; Andrew D A Maidment; David P Cormode
Journal:  Nanoscale       Date:  2021-01-08       Impact factor: 7.790

8.  Comprehensive Evaluation of the Toxicity and Biosafety of Plasma Polymerized Nanoparticles.

Authors:  Praveesuda L Michael; Yuen Ting Lam; Juichien Hung; Richard P Tan; Miguel Santos; Steven G Wise
Journal:  Nanomaterials (Basel)       Date:  2021-04-29       Impact factor: 5.076

Review 9.  Optimizing nanoparticle design and surface modification toward clinical translation.

Authors:  Isabel Gessner
Journal:  MRS Bull       Date:  2021-07-14       Impact factor: 4.882

Review 10.  Peptide-Enabled Targeted Delivery Systems for Therapeutic Applications.

Authors:  Mingpeng Liu; Xiaocui Fang; Yanlian Yang; Chen Wang
Journal:  Front Bioeng Biotechnol       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.